Physicians' Academy for Cardiovascular Education

Results with novel FXI inhibitor in AF set the stage for phase 3 trials

3' education - Nov. 16, 2023 - Christian Ruff, MD - Boston, MA, US

Educational information

This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, US.


Christian Ruff, MD is Director, General Cardiology, Cardiovascular Division, Brigham and Women's Hospital and Associate Professor, Harvard Medical School; Senior Investigator, TIMI Group in Boston, MA, US.


This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the AZALEA-TIMI 71 trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: